Table 2.
Number | Metabolites | Formula | Category | Mass(M/Z) 2 | RT(Min) 1 | LA+LPS VS LPS | LA+LPS VS ANT+LPS | ||
---|---|---|---|---|---|---|---|---|---|
FC | P value | FC | P value | ||||||
1 | 3,8-Dihydroxy-6-methoxy-7(11)-eremophilen-12,8-olide | C16H24O5 | Lipids and lipid-like molecules | 331.1299 | 3.5549 | 1.2581* | 0.0436 | 1.2432 | 0.0663 |
2 | PS(14:1(9Z)/18:0) | C38H72NO10P | Lipids and lipid-like molecules | 756.4795 | 9.2650 | 1.3076** | 0.0021 | 1.3434*** | 0.0000 |
3 | Mactraxanthin | C40H60O6 | Lipids and lipid-like molecules | 678.4710 | 9.1518 | 1.2785** | 0.0023 | 1.1194** | 0.0023 |
4 | 12-Hydroxy-8,10-octadecadienoic acid | C18H32O3 | Lipids and lipid-like molecules | 295.2275 | 8.3016 | 1.2530* | 0.0224 | 1.4020* | 0.0164 |
5 | 3,4-Dimethyl-5-pentyl-2-furanpentadecanoic acid | C26H46O3 | Lipids and lipid-like molecules | 451.3427 | 9.1118 | 1.2052* | 0.0427 | 1.3609* | 0.0147 |
6 | Lactosylceramide (d18:1/12:0) | C42H79NO13 | Lipids and lipid-like molecules | 788.5444 | 9.3136 | 0.9707 | 0.7236 | 0.7928* | 0.0327 |
7 | 3-hydroxytetradecanoyl carnitine | C21H41NO5 | Lipids and lipid-like molecules | 370.2956 | 6.3694 | 0.9406 | 0.3435 | 0.7980* | 0.0152 |
8 | Quinquenoside F1 | C42H74O15 | Lipids and lipid-like molecules | 836.5421 | 9.3136 | 1.0397 | 0.5084 | 0.8283* | 0.0446 |
9 | PS(18:3(9Z,12Z,15Z)/20:0) | C44H80NO10P | Lipids and lipid-like molecules | 814.5597 | 9.4268 | 0.9547 | 0.5517 | 0.7819* | 0.0301 |
10 | PS(14:0/24:1(15Z)) | C44H84NO10P | Lipids and lipid-like molecules | 840.5743 | 9.6857 | 0.9879 | 0.7992 | 0.8057* | 0.0263 |
11 | PE-NMe2(16:0/18:4(6Z,9Z,12Z,15Z)) | C41H74NO8P | Lipids and lipid-like molecules | 772.5495 | 9.6372 | 0.9924 | 0.9230 | 0.8021* | 0.0390 |
12 | Monoisobutyl phthalic acid | C12H14O4 | Benzenoids | 205.0861 | 7.0005 | 1.5611*** | 0.0000 | 1.0311 | 0.0744 |
13 | 1-H-Inden-1-one,2,3-dihydro-3,3,5,6-tetramethyl | C13H16O | Benzenoids | 233.0922 | 1.6437 | 1.2735* | 0.0229 | 1.4919*** | 0.0000 |
14 | 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylpropanamide | C14H17N3O5 | Benzenoids | 325.1509 | 1.0932 | 1.0824 | 0.3580 | 1.2394* | 0.0339 |
15 | 2’’,4’’,6’’-Triacetylglycitin | C28H28O13 | Phenylpropanoids and polyketides | 614.1822 | 5.6900 | 0.7859** | 0.0065 | 0.7612** | 0.0028 |
16 | Daidzein | C15H10O4 | Phenylpropanoids and polyketides | 255.0654 | 3.4566 | 1.2876* | 0.0256 | 1.3217* | 0.0146 |
17 | Indole-3-carbinol | C9H9NO | Organoheterocyclic compounds | 189.1021 | 1.5305 | 1.2283* | 0.0328 | 0.9617 | 0.7315 |
18 | Plantagonine | C10H11NO2 | Organoheterocyclic compounds | 178.0863 | 2.3075 | 1.1020 | 0.1699 | 1.2178** | 0.0099 |
19 | Spirolide B | C42H63NO7 | Organoheterocyclic compounds | 694.4662 | 8.9901 | 1.3447** | 0.0034 | 1.1670 | 0.0009 |
20 | Hydroxynalidixic acid | C12H12N2O4 | Organoheterocyclic compounds | 231.0765 | 1.1904 | 1.1852 | 0.1249 | 1.2832* | 0.0313 |
21 | Hydroxyphenylacetylglycine | C10H11NO4 | Organic acids and derivatives | 208.0608 | 1.5246 | 1.0658 | 0.1244 | 1.2213** | 0.0022 |
22 | Alanylclavam | C8H12N2O4 | Others | 201.0871 | 0.8988 | 1.1186 | 0.1095 | 1.2082* | 0.0128 |
23 | Nicotyrine | C10H10N2 | Others | 159.0917 | 2.3075 | 1.1694 | 0.1763 | 1.3194* | 0.0288 |
24 | 2-Ethylacrylylcarnitine | C12H21NO4 | Others | 244.1545 | 3.2139 | 0.9204 | 0.3214 | 0.7578* | 0.0175 |
25 | (3-Arylcarbonyl)-alanine | C10H11NO3 | Others | 194.0813 | 1.4333 | 1.1501 | 0.0756 | 1.3030** | 0.0031 |
26 | PGPC | C29H56NO10P | Others | 608.3567 | 8.1695 | 1.3652** | 0.0066 | 1.2813*** | 0.0006 |
27 | PAz-PC | C33H64NO10P | Others | 666.4351 | 8.4563 | 1.2456** | 0.0068 | 1.1313 | 0.0026 |
1RT means retention time. 2FC is the fold change (differential multiple) of the metabolite expression between groups (LA vs. LA+LPS, LA+LPS vs. ANT+LPS). *P < 0.05, **P < 0.01, ***P < 0.001.